Neuroprotective effects of rutin on ASH neurons in Caenorhabditis elegans model of Huntington’s disease

2021 ◽  
pp. 1-14
Author(s):  
Larissa Marafiga Cordeiro ◽  
Marcell Valandro Soares ◽  
Aline Franzen da Silva ◽  
Marina Lopes Machado ◽  
Fabiane Bicca Obetine Baptista ◽  
...  
2021 ◽  
Vol 14 (10) ◽  
pp. 1044
Author(s):  
Letizia Pruccoli ◽  
Carlo Breda ◽  
Gabriella Teti ◽  
Mirella Falconi ◽  
Flaviano Giorgini ◽  
...  

Huntington’s disease (HD) is a neurodegenerative disorder caused by an abnormal CAG trinucleotide repeat expansion within exon 1 of the huntingtin (HTT) gene. This mutation leads to the production of mutant HTT (mHTT) protein which triggers neuronal death through several mechanisms. Here, we investigated the neuroprotective effects of esculetin (ESC), a bioactive phenolic compound, in an inducible PC12 model and a transgenic Drosophila melanogaster model of HD, both of which express mHTT fragments. ESC partially inhibited the progression of mHTT aggregation and reduced neuronal death through its ability to counteract the oxidative stress and mitochondria impairment elicited by mHTT in the PC12 model. The ability of ESC to counteract neuronal death was also confirmed in the transgenic Drosophila model. Although ESC did not modify the lifespan of the transgenic Drosophila, it still seemed to have a positive impact on the HD phenotype of this model. Based on our findings, ESC may be further studied as a potential neuroprotective agent in a rodent transgenic model of HD.


2020 ◽  
Vol 141 ◽  
pp. 111323 ◽  
Author(s):  
Larissa Marafiga Cordeiro ◽  
Marina Lopes Machado ◽  
Aline Franzen da Silva ◽  
Fabiane Bicca Obetine Baptista ◽  
Tássia Limana da Silveira ◽  
...  

Lab on a Chip ◽  
2019 ◽  
Vol 19 (1) ◽  
pp. 120-135 ◽  
Author(s):  
Huseyin Baris Atakan ◽  
Matteo Cornaglia ◽  
Laurent Mouchiroud ◽  
Johan Auwerx ◽  
Martin A. M. Gijs

We performed automated high-content phenotyping of Caenorhabditis elegans and demonstrated that dietary restriction slows down Huntington's disease development.


2007 ◽  
Vol 35 (1) ◽  
pp. 221-222 ◽  
Author(s):  
Ferdinando Squitieri ◽  
Andrea Ciammola ◽  
Claudio Colonnese ◽  
Andrea Ciarmiello

Author(s):  
Rahul ◽  
Yasir Hasan Siddique

: Neurodegenerative diseases like Alzheimer's disease, Parkinson's disease, Huntington’s disease, Multiple Sclerosis and Ischemic stroke have become a major health problem worldwide. Pre-clinical studies have demonstrated the beneficial effects of flavonoids on neurodegenerative diseases and suggesting them to be used as therapeutic agents. Kaempferol is found in many plants such as tea, beans, broccoli,strawberriesand has neuroprotective effects against the development of many neurodegenerative diseases such as Parkinson's disease, Alzheimer's disease and Huntington's disease. The present study summarizesthe neuroprotective effects of kaempferol in various models of neurodegenerative diseases. Kaempferol delays the initiation as well as the progression of neurodegenerative disorders by acting as a scavenger of free radicals and preserving the activity of various antioxidant enzymes. Kaempferolcan crossthe blood-brain barrier (BBB), and therefore results inan enhanced protective effect. The multi-target property of kaempferol makes it a potential dietary supplement in preventing and treating neurodegenerative diseases.


2007 ◽  
Vol 27 (47) ◽  
pp. 12908-12915 ◽  
Author(s):  
E. C. Stack ◽  
A. Dedeoglu ◽  
K. M. Smith ◽  
K. Cormier ◽  
J. K. Kubilus ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document